JP2024504611A5 - - Google Patents
Info
- Publication number
- JP2024504611A5 JP2024504611A5 JP2023542653A JP2023542653A JP2024504611A5 JP 2024504611 A5 JP2024504611 A5 JP 2024504611A5 JP 2023542653 A JP2023542653 A JP 2023542653A JP 2023542653 A JP2023542653 A JP 2023542653A JP 2024504611 A5 JP2024504611 A5 JP 2024504611A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- gla
- nucleic acid
- signal peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163137235P | 2021-01-14 | 2021-01-14 | |
| US63/137,235 | 2021-01-14 | ||
| US202163264356P | 2021-11-19 | 2021-11-19 | |
| US63/264,356 | 2021-11-19 | ||
| PCT/US2022/070184 WO2022155665A1 (en) | 2021-01-14 | 2022-01-13 | Compositions and methods for treating fabry disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024504611A JP2024504611A (ja) | 2024-02-01 |
| JP2024504611A5 true JP2024504611A5 (cg-RX-API-DMAC7.html) | 2025-01-08 |
Family
ID=82448637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542653A Withdrawn JP2024504611A (ja) | 2021-01-14 | 2022-01-13 | ファブリー病を治療するための組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240301380A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4277988A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024504611A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230131246A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022207185A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3208153A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2023002015A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2023010599A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304273A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023008362A (cg-RX-API-DMAC7.html) |
| PE (1) | PE20240915A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022155665A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022381751A1 (en) * | 2021-11-03 | 2024-05-16 | Sangamo Therapeutics, Inc. | Methods for use of viral vector constructs for the treatment of fabry disease |
| AU2024241509A1 (en) * | 2023-03-20 | 2025-09-25 | Spark Therapeutics, Inc. | Ppt1 gene therapy |
| CN117551636B (zh) * | 2023-04-30 | 2024-11-08 | 四川至善唯新生物科技有限公司 | 工程化α-GAL A肽及其功能变体和治疗法布里病的相关方法 |
| US20240360431A1 (en) * | 2023-04-30 | 2024-10-31 | Sichuan Real&Best Biotech Co., Ltd. | Engineered alpha-galactosidase a (a-gal a) peptides and functional variants thereof and associated methods of treating fabry disease |
| WO2025264565A1 (en) * | 2024-06-17 | 2025-12-26 | Spark Therapeutics, Inc. | Promoters |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013151664A1 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| JP7114485B2 (ja) * | 2016-05-18 | 2022-08-08 | モデルナティエックス インコーポレイテッド | ファブリー病の治療のためのα-ガラクトシダーゼAをコードするポリヌクレオチド |
| KR102712926B1 (ko) * | 2016-10-20 | 2024-10-07 | 상가모 테라퓨틱스, 인코포레이티드 | 파브리병의 치료를 위한 방법 및 조성물 |
| SG11202011191WA (en) * | 2018-05-16 | 2020-12-30 | Spark Therapeutics Inc | Codon-optimized acid αlpha-glucosidase expression cassettes and methods of using same |
| BR112021009913A2 (pt) * | 2018-12-05 | 2021-08-17 | Abeona Therapeutics, Inc. | vetor viral adeno-associado recombinante para inserção gênica |
| US12163425B2 (en) * | 2020-03-13 | 2024-12-10 | Baker Hughes Oilfield Operations Llc | Automated geosteering based on a distance to oil-water contact |
-
2022
- 2022-01-13 PE PE2023002056A patent/PE20240915A1/es unknown
- 2022-01-13 MX MX2023008362A patent/MX2023008362A/es unknown
- 2022-01-13 JP JP2023542653A patent/JP2024504611A/ja not_active Withdrawn
- 2022-01-13 CA CA3208153A patent/CA3208153A1/en active Pending
- 2022-01-13 WO PCT/US2022/070184 patent/WO2022155665A1/en not_active Ceased
- 2022-01-13 AU AU2022207185A patent/AU2022207185A1/en not_active Abandoned
- 2022-01-13 US US18/261,285 patent/US20240301380A1/en active Pending
- 2022-01-13 EP EP22740258.3A patent/EP4277988A4/en not_active Withdrawn
- 2022-01-13 KR KR1020237027400A patent/KR20230131246A/ko not_active Withdrawn
-
2023
- 2023-07-05 IL IL304273A patent/IL304273A/en unknown
- 2023-07-11 CL CL2023002015A patent/CL2023002015A1/es unknown
- 2023-08-14 CO CONC2023/0010599A patent/CO2023010599A2/es unknown